Herrmann John A III 4
4 · NOVAVAX INC · Filed Mar 14, 2023
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Herrmann John A III
SVP, General Counsel
Transactions
- Exercise/Conversion
Common Stock
2023-03-10$6.52/sh+4,609$30,051→ 13,058 total - Tax Payment
Common Stock
2023-03-10$6.52/sh−1,780$11,606→ 11,278 total - Exercise/Conversion
Restricted Stock Units
2023-03-10−4,609→ 9,216 total→ Common Stock (4,609 underlying)
Holdings
- 3,384(indirect: By Spouse)
Common Stock
Footnotes (4)
- [F1]The shares were received by the reporting person in connection with vesting of restricted stock units ("RSUs").
- [F2]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
- [F3]Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
- [F4]The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 10, 2022 grant date, in each case subject to continued employment through such vesting date.